Cancer patients don't trust docs: survey

Share this article:
A survey of patients at Harvard's Dana-Farber Cancer Institute found that 11% said ads for cancer-related drugs had made them less confident in their providers' judgment.

Of the 348 respondents to the survey, in the Journal of Clinical Oncology, 86% were aware of DTC advertising, particularly TV spots (77%), with little variation across clinical or sociodemographic factors except that patients were more likely to be aware of products specific to their cancer types. Of those aware of ads, 17.3% said they'd talked to their healthcare provider about an advertised medication. Patient perceptions of DTC ads were favorable, particularly among non-college graduates.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.